Mia Levy

Cancer Center investigators awarded Komen grants

Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.

VICC’s Levy to lead Rush University Cancer Center

Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.

By Tom Wilemon

June 8, 2017

Project reveals importance of cancer gene mutation testing

An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.

By VUMC News and Communications

January 19, 2017

VICC joins cancer genomic data sharing initiative

Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine.

By VUMC News and Communications

June 2, 2016

VICC’s Levy named Komen Scholar for breast cancer research

Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar by the Susan G. Komen organization.

By VUMC News and Communications

May 26, 2016

Precision medicine already changing cancer treatment strategies

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.